Evidence map›Paper›PMID 34890565›Full record

ArticleMolecular cell2022

MYC assembles and stimulates topoisomerases 1 and 2 in a "topoisome".

Subhendu K Das, Vladislav Kuzin, Donald P Cameron, Suzanne Sanford, Rajiv Kumar Jha, Zuqin Nie, Marta Trullols Rosello, Ronald Holewinski, Thorkell Andresson, Jan Wisniewski and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. DNA topological regulation in RNA polymerase II transcription.Cellular & molecular biology letters · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Dynamic Supercoiling Sponsors Transcription Amplification by MYC.bioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Subhendu K DasLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA.
Vladislav KuzinDepartment of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.
Donald P CameronDepartment of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.
Suzanne SanfordLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA.
Rajiv Kumar JhaLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA.
Zuqin NieLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA.
Marta Trullols RoselloDepartment of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.
Ronald HolewinskiFrederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Bethesda, MD 21701, USA.
Thorkell AndressonFrederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Bethesda, MD 21701, USA.
Jan WisniewskiConfocal Microscopy and Digital Imaging Facility, National Cancer Institute, Bethesda, MD 20892, USA.
Toyoaki NatsumeDepartment of Chromosome Science, National Institute of Genetics, Shizuoka 411-8540, Japan; Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
David H PriceDepartment of Biochemistry, University of Iowa, Iowa City, IA 52242, USA.
Brian A LewisLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA.
Fedor KouzineLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA.
David LevensLaboratory of Pathology, National Cancer Institute, Bethesda, MD 20814, USA. Electronic address: levensd@mail.nih.gov.
Laura BaranelloDepartment of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden. Electronic address: laura.baranello@ki.se.
National Cancer Institute · USKarolinska Institutet · SELeidos (United States) · USNational Institute of Genetics · JPNational Institutes of Health · USUniversity of Iowa · US

Funding

The genome-wide function of supercoiling and alternative DNA conformationsZIABC011011 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEVENS, DAVID L. · 2009 to 2025
$16.1M
c-Myc FunctionZIABC011465 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEVENS, DAVID L. · 2012 to 2025
$8.6M
EIB Microscopy Core FacilityZICBC010915 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WISNIEWSKI, JAN · 2009 to 2025
$6.1M
RNA polymerase II elongation controlR35GM126908 · NIGMS · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 2018 to 2022
$2.9M
Intramural NIH HHS ZIA BC011465NIGMS NIH HHS R35 GM126908
6 · The paper itself

Abstract

High-intensity transcription and replication supercoil DNA to levels that can impede or halt these processes. As a potent transcription amplifier and replication accelerator, the proto-oncogene MYC must manage this interfering torsional stress. By comparing gene expression with the recruitment of topoisomerases and MYC to promoters, we surmised a direct association of MYC with topoisomerase 1 (TOP1) and TOP2 that was confirmed in vitro and in cells. Beyond recruiting topoisomerases, MYC directly stimulates their activities. We identify a MYC-nucleated "topoisome" complex that unites TOP1 and TOP2 and increases their levels and activities at promoters, gene bodies, and enhancers. Whether TOP2A or TOP2B is included in the topoisome is dictated by the presence of MYC versus MYCN, respectively. Thus, in vitro and in cells, MYC assembles tools that simplify DNA topology and promote genome function under high output conditions.

Indexed as

Transcription, GeneticAnimalsDNA, NeoplasmDNA ReplicationDNA, SuperhelicalDNA Topoisomerases, Type IDNA Topoisomerases, Type IIEnzyme ActivationGene Expression Regulation, NeoplasticHCT116 CellsHumansK562 CellsMultienzyme ComplexesNeoplasmsPoly-ADP-Ribose Binding ProteinsPromoter Regions, GeneticDNA, NeoplasmDNA, SuperhelicalDNA Topoisomerases, Type IDNA Topoisomerases, Type IIMultienzyme ComplexesMYC protein, humanPoly-ADP-Ribose Binding ProteinsProto-Oncogene Proteins c-mycTOP1 protein, humanTOP2A protein, humanTOP2B protein, humancancerchromatinDNA topologyMycpolymerasesupercoilingTOP1TOP2TopoisomeraseTranscription

Identifiers

PMID34890565
PMCPMC8750365
OpenAlexW4200614588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.